vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and AVIENT CORP (AVNT). Click either name above to swap in a different company.
AVIENT CORP is the larger business by last-quarter revenue ($760.6M vs $359.9M, roughly 2.1× AdvanSix Inc.). AVIENT CORP runs the higher net margin — 2.2% vs -0.8%, a 3.0% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -4.2%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
ASIX vs AVNT — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $760.6M |
| Net Profit | $-2.8M | $16.9M |
| Gross Margin | 7.6% | 30.2% |
| Operating Margin | -0.7% | 5.2% |
| Net Margin | -0.8% | 2.2% |
| Revenue YoY | 9.4% | 1.9% |
| Net Profit YoY | -892.9% | -65.0% |
| EPS (diluted) | $-0.11 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $760.6M | ||
| Q3 25 | $374.5M | $806.5M | ||
| Q2 25 | $410.0M | $866.5M | ||
| Q1 25 | $377.8M | $826.6M | ||
| Q4 24 | $329.1M | $746.5M | ||
| Q3 24 | $398.2M | $815.2M | ||
| Q2 24 | $453.5M | $849.7M | ||
| Q1 24 | $336.8M | $829.0M |
| Q4 25 | $-2.8M | $16.9M | ||
| Q3 25 | $-2.6M | $32.6M | ||
| Q2 25 | $31.4M | $52.6M | ||
| Q1 25 | $23.3M | $-20.2M | ||
| Q4 24 | $352.0K | $48.3M | ||
| Q3 24 | $22.3M | $38.2M | ||
| Q2 24 | $38.9M | $33.6M | ||
| Q1 24 | $-17.4M | $49.4M |
| Q4 25 | 7.6% | 30.2% | ||
| Q3 25 | 6.8% | 30.4% | ||
| Q2 25 | 14.3% | 32.1% | ||
| Q1 25 | 14.2% | 31.8% | ||
| Q4 24 | 3.4% | 34.8% | ||
| Q3 24 | 14.4% | 32.1% | ||
| Q2 24 | 17.9% | 30.3% | ||
| Q1 24 | 0.9% | 33.6% |
| Q4 25 | -0.7% | 5.2% | ||
| Q3 25 | -0.9% | 8.3% | ||
| Q2 25 | 7.7% | 11.1% | ||
| Q1 25 | 7.7% | 0.1% | ||
| Q4 24 | -3.9% | 11.5% | ||
| Q3 24 | 7.5% | 9.5% | ||
| Q2 24 | 11.5% | 8.5% | ||
| Q1 24 | -7.0% | 11.3% |
| Q4 25 | -0.8% | 2.2% | ||
| Q3 25 | -0.7% | 4.0% | ||
| Q2 25 | 7.7% | 6.1% | ||
| Q1 25 | 6.2% | -2.4% | ||
| Q4 24 | 0.1% | 6.5% | ||
| Q3 24 | 5.6% | 4.7% | ||
| Q2 24 | 8.6% | 4.0% | ||
| Q1 24 | -5.2% | 6.0% |
| Q4 25 | $-0.11 | $0.18 | ||
| Q3 25 | $-0.10 | $0.36 | ||
| Q2 25 | $1.15 | $0.57 | ||
| Q1 25 | $0.86 | $-0.22 | ||
| Q4 24 | $0.02 | $0.53 | ||
| Q3 24 | $0.82 | $0.41 | ||
| Q2 24 | $1.43 | $0.36 | ||
| Q1 24 | $-0.65 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | $1.9B |
| Stockholders' EquityBook value | $815.2M | $2.4B |
| Total Assets | $1.7B | $6.0B |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $20.6M | — |
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | $815.2M | $2.4B | ||
| Q3 25 | $818.2M | $2.4B | ||
| Q2 25 | $823.7M | $2.4B | ||
| Q1 25 | $794.4M | $2.3B | ||
| Q4 24 | $774.6M | $2.3B | ||
| Q3 24 | $766.4M | $2.4B | ||
| Q2 24 | $746.6M | $2.3B | ||
| Q1 24 | $713.2M | $2.3B |
| Q4 25 | $1.7B | $6.0B | ||
| Q3 25 | $1.7B | $6.1B | ||
| Q2 25 | $1.6B | $6.1B | ||
| Q1 25 | $1.6B | $5.8B | ||
| Q4 24 | $1.6B | $5.8B | ||
| Q3 24 | $1.5B | $6.0B | ||
| Q2 24 | $1.5B | $5.9B | ||
| Q1 24 | $1.5B | $5.9B |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | — | 0.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $167.8M |
| Free Cash FlowOCF − Capex | $36.1M | $125.4M |
| FCF MarginFCF / Revenue | 10.0% | 16.5% |
| Capex IntensityCapex / Revenue | 7.7% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 9.93× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $195.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $167.8M | ||
| Q3 25 | $26.6M | $72.1M | ||
| Q2 25 | $21.1M | $112.8M | ||
| Q1 25 | $11.4M | $-51.1M | ||
| Q4 24 | $64.2M | $122.6M | ||
| Q3 24 | $57.3M | $71.1M | ||
| Q2 24 | $50.2M | $105.9M | ||
| Q1 24 | $-36.2M | $-42.8M |
| Q4 25 | $36.1M | $125.4M | ||
| Q3 25 | $66.0K | $47.4M | ||
| Q2 25 | $-7.2M | $85.8M | ||
| Q1 25 | $-22.6M | $-63.6M | ||
| Q4 24 | $29.8M | $81.5M | ||
| Q3 24 | $26.8M | $46.1M | ||
| Q2 24 | $16.7M | $74.5M | ||
| Q1 24 | $-71.6M | $-67.2M |
| Q4 25 | 10.0% | 16.5% | ||
| Q3 25 | 0.0% | 5.9% | ||
| Q2 25 | -1.7% | 9.9% | ||
| Q1 25 | -6.0% | -7.7% | ||
| Q4 24 | 9.1% | 10.9% | ||
| Q3 24 | 6.7% | 5.7% | ||
| Q2 24 | 3.7% | 8.8% | ||
| Q1 24 | -21.3% | -8.1% |
| Q4 25 | 7.7% | 5.6% | ||
| Q3 25 | 7.1% | 3.1% | ||
| Q2 25 | 6.9% | 3.1% | ||
| Q1 25 | 9.0% | 1.5% | ||
| Q4 24 | 10.4% | 5.5% | ||
| Q3 24 | 7.7% | 3.1% | ||
| Q2 24 | 7.4% | 3.7% | ||
| Q1 24 | 10.5% | 2.9% |
| Q4 25 | — | 9.93× | ||
| Q3 25 | — | 2.21× | ||
| Q2 25 | 0.67× | 2.14× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | 2.54× | ||
| Q3 24 | 2.57× | 1.86× | ||
| Q2 24 | 1.29× | 3.15× | ||
| Q1 24 | — | -0.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
